Koers Panacos Pharmaceuticals, Inc. Other OTC
Aandelen
PANC
US69811Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2006 | 284K 263K | Omzet 2007 | 180K 167K | Marktkapitalisatie | 42,29 mln. 39,18 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -38 mln. -35,2 mln. | Nettowinst (verlies) 2007 | -37 mln. -34,28 mln. | EV/omzet 2006 | 504 x |
Nettoliquiditeiten 2006 | 60,4 mln. 55,96 mln. | Nettoliquiditeiten 2007 | 32,58 mln. 30,19 mln. | EV/omzet 2007 | 53,9 x |
K/w-verhouding 2006 |
-5,32
x | K/w-verhouding 2007 |
-1,12
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,73% | 122 mld. | |
+16,69% | 113 mld. | |
+17,55% | 26,22 mld. | |
-24,21% | 19,01 mld. | |
-19,14% | 15,71 mld. | |
-18,11% | 15,22 mld. | |
-46,81% | 14,72 mld. | |
+59,31% | 14,58 mld. | |
+5,09% | 13,84 mld. |